Literature DB >> 22226118

Follicular lymphoma: prognostic factors, conventional therapies, and hematopoietic cell transplantation.

Laurie H Sehn1, Timothy S Fenske, Ginna G Laport.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22226118     DOI： 10.1016/j.bbmt.2011.11.012

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  8 in total

1.  Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma.

Authors:  Milena Krajnović; Milica Radojković; Radoslav Davidović; Bogomir Dimitrijević; Koviljka Krtolica
Journal:  Med Oncol       Date:  2012-12-30       Impact factor: 3.064

2.  Allogeneic Transplantation for Follicular Lymphoma: Does One Size Fit All?

Authors:  Mehdi Hamadani; Mary M Horowitz
Journal:  J Oncol Pract       Date:  2017-12       Impact factor: 3.840

3.  BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.

Authors:  Cristina Correia; Paula A Schneider; Haiming Dai; Ahmet Dogan; Matthew J Maurer; Amy K Church; Anne J Novak; Andrew L Feldman; Xiaosheng Wu; Husheng Ding; X Wei Meng; James R Cerhan; Susan L Slager; William R Macon; Thomas M Habermann; Judith E Karp; Steven D Gore; Neil E Kay; Diane F Jelinek; Thomas E Witzig; Grzegorz S Nowakowski; Scott H Kaufmann
Journal:  Blood       Date:  2014-12-01       Impact factor: 22.113

4.  Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party.

Authors:  Silvia Montoto; Paolo Corradini; Martin Dreyling; Michele Ghielmini; Eva Kimby; Armando López-Guillermo; Stephen Mackinnon; Robert E Marcus; Gilles Salles; Harry C Schouten; Anna Sureda; Peter Dreger
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

5.  Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report.

Authors:  Ivana N Micallef; Patrick J Stiff; Auayporn P Nademanee; Richard T Maziarz; Mitchell E Horwitz; Edward A Stadtmauer; Jonathan L Kaufman; John M McCarty; Rita Vargo; Peter D Cheverton; Martin Struijs; Brian Bolwell; John F DiPersio
Journal:  Biol Blood Marrow Transplant       Date:  2018-02-02       Impact factor: 5.742

6.  Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders.

Authors:  Shuhua Yi; Zengjun Li; Dehui Zou; Wenjie Xiong; Heng Li; Rui Cui; Chengwen Li; Yuting Yan; Wei Liu; Rui Lv; Zhen Yu; Weiwei Chen; Yan Xu; Gang An; Huijun Wang; Kun Ru; Tao Cheng; Jianxiang Wang; Lugui Qiu
Journal:  Oncotarget       Date:  2017-12-15

7.  Controversies and recent advances in hematopoietic cell transplantation for follicular non-hodgkin lymphoma.

Authors:  Abraham S Kanate; Mohamed A Kharfan-Dabaja; Mehdi Hamadani
Journal:  Bone Marrow Res       Date:  2012-10-11

8.  Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As2O3) and all-trans retinoic acid (ATRA).

Authors:  Preetesh Jain; Sergej Konoplev; Ohad Benjamini; Jorge Romagura; Jan A Burger
Journal:  Blood Res       Date:  2018-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.